A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma
- 1 August 1996
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 98 (2) , 317-324
- https://doi.org/10.1016/s0091-6749(96)70156-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Troleandomycin in the treatment of difficult asthmaJournal of Allergy and Clinical Immunology, 1993
- Methotrexate in the treatment of steroid-dependent asthmaJournal of Allergy and Clinical Immunology, 1991
- Association of Asthma with Serum IgE Levels and Skin-Test Reactivity to AllergensNew England Journal of Medicine, 1989
- An open study of Auranofin in the treatment of steroid-dependent asthmaJournal of Allergy and Clinical Immunology, 1988
- Auranofin modulates mast cell histamine and polymorphonuclear leukocyte collagenase releaseInflammation Research, 1986
- Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofinInflammation Research, 1986
- Inhibition by auranofin of pharmacologic and antigen-induced contractions of the isolated guinea pig tracheaJournal of Allergy and Clinical Immunology, 1986
- Effects of auranofin on leukotriene production and leukotriene stimulated neutrophil functionInflammation Research, 1984
- Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritisArthritis & Rheumatism, 1983
- Bronchial responsiveness to acethylcholine in patients with bronchial asthma after long-term treatment with gold saltJournal of Allergy and Clinical Immunology, 1981